Targeting the cause of opioid-induced constipation with PAMORAs
This webinar has been initiated and commissioned by Sandoz Ltd and organised in partnership with Guidelines.
View prescribing information
UK/MKT/RZM/20-0032af
Promotional content
ClinOwl - A new resource for healthcare professionals
A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.
NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation
The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/P/RZM/20-0016c October 2020
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015
COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014
Why you might want to review patients with COPD receiving a LAMA
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013
COPD: Have you done enough to implement guidelines?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012
Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.
Management of common eye conditions: blepharitis
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.
Management of common eye conditions: conjunctivitis
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.
Management of common eye conditions: dry eye
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.
Management of common eye conditions: corneal and subtarsal foreign bodies
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.
Management of common eye conditions: chalazion (meibomian cyst)
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the presentation and management of chalazion (meibomian cyst).
Management of common eye conditions: corneal abrasion
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses the causes, symptoms, and treatment of corneal abrasion.
Management of common eye conditions: subconjunctival haemorrhage
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance and causes of subconjunctival haemorrhage.
Management of common eye conditions: episcleritis
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the causes, symptoms, and treatment of episcleritis.
Management of common eye conditions: stye
Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance, symptoms, and treatment of stye.
Management of common eye conditions: Glaucoma and the #knowyourdrops campaign
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses treatment of glaucoma and techniques for correct eye drop administration.
DuoResp® Spiromax® (budesonide/formoterol)
This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020
Anticholinergics and cognitive impairment in the treatment of overactive bladder
This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information
REG/2020/224 September 2020
Identifying and managing allergic rhinitis in the asthma population
This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.
Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.
Inhaler choice guideline
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.
Women of child-bearing age with inflammatory rheumatic diseases guideline
This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.